0001493152-23-043892.txt : 20231206 0001493152-23-043892.hdr.sgml : 20231206 20231206164509 ACCESSION NUMBER: 0001493152-23-043892 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231115 FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FASHEK CHRISTOPHER M CENTRAL INDEX KEY: 0001279063 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36445 FILM NUMBER: 231470170 MAIL ADDRESS: STREET 1: 8023 VANTAGE DR CITY: SAN ANTONIO STATE: TX ZIP: 78230 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NanoVibronix, Inc. CENTRAL INDEX KEY: 0001326706 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 EXECUTIVE BLVD CITY: ELMSFORD STATE: NY ZIP: 10523 BUSINESS PHONE: (914) 233-3004 MAIL ADDRESS: STREET 1: 525 EXECUTIVE BLVD CITY: ELMSFORD STATE: NY ZIP: 10523 FORMER COMPANY: FORMER CONFORMED NAME: Nano Vibronix, Inc. DATE OF NAME CHANGE: 20111206 FORMER COMPANY: FORMER CONFORMED NAME: Nano Vibronix Inc DATE OF NAME CHANGE: 20050510 4 1 ownership.xml X0508 4 2023-11-15 0 0001326706 NanoVibronix, Inc. NAOV 0001279063 FASHEK CHRISTOPHER M C/O NANOVIBRONIX, INC. 525 EXECUTIVE BOULEVARD ELMSFORD NY 10523 1 0 0 0 0 Option to Purchase Common Stock 1.24 2023-11-15 4 A 0 14000 0 A 2033-11-15 Common Stock 14000 14000 D Options to Purchase Common Stock 20.20 2023-11-29 4 D 0 1125 0 D 2028-08-14 Common Stock 1125 0 D Options to Purchase Common Stock 41.40 2023-11-29 4 D 0 2100 0 D 2020-07-07 2030-07-07 Common Stock 2100 0 D Options to Purchase Common Stock 14.40 2023-11-29 4 D 0 2500 0 D 2020-10-01 2030-10-01 Common Stock 2500 0 D Options to Purchase Common Stock 16.80 2023-11-29 4 D 0 6000 0 D 2030-12-22 Common Stock 6000 0 D Options to Purchase Common Stock 20.20 2023-11-29 4 D 0 4000 0 D 2031-12-28 Common Stock 4000 0 D 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019. 20% of the option vested on December 22, 2020 (the "2020 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. 25% of the option vested on December 29, 2021 (the "2021 Date of Grant"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations. /s/ Christopher M. Fashek 2023-12-06